- CAS 104255-56-3
- Purity 99%
Factory supply 4H-1,4-Benzoxazin-4-amine,2,3-dihydro-(9CI) 104255-56-3 with sufficient production capacity
- Molecular Formula: C8H10N2O
- Molecular Weight: 150.18
- Vapor Pressure: 0.005mmHg at 25°C
- Refractive Index: 1.591
- Boiling Point: 276.815 °C at 760 mmHg
- Flash Point: 121.214 °C
- PSA: 38.49000
- Density: 1.192 g/cm3
- LogP: 1.52440
4H-1,4-Benzoxazin-4-amine,2,3-dihydro-(9CI)(Cas 104255-56-3) Usage
|
Use Description |
4H-1,4-Benzoxazin-4-amine,2,3-dihydro-(9CI) is a chemical compound with diverse applications across various fields. In organic chemistry and pharmaceutical research, it can serve as a valuable scaffold or starting material for the synthesis of complex organic molecules, including potential drug candidates. Its unique chemical structure and functional groups make it a useful building block for the development of pharmaceuticals targeting various medical conditions. Additionally, in the field of agrochemistry, 4H-1,4-Benzoxazin-4-amine,2,3-dihydro-(9CI) may find use in the synthesis of agrochemicals and pesticides, contributing to crop protection and weed control efforts in agriculture. However, the specific role and significance of 4H-1,4-Benzoxazin-4-amine,2,3-dihydro-(9CI) can vary depending on the specific research or industrial requirements within each field, underscoring its potential versatility and importance in diverse scientific and industrial applications. |
InChI:InChI=1/C8H10N2O/c9-10-5-6-11-8-4-2-1-3-7(8)10/h1-4H,5-6,9H2
104255-56-3 Relevant articles
ANTHELMINTIC HETEROCYCLIC COMPOUNDS
-
Page/Page column 199-201, (2021/12/08)
This invention provides for compounds of...
BICYCLIC DERIVATIVES FOR TREATING ENDOPARASITES
-
Page/Page column 40; 73, (2020/12/29)
The present invention provides compounds...
Ruthenium(II)-Catalyzed Traceless C?H Functionalization Using an N?N Bond as an Internal Oxidant
Zhou, Shuguang,Wang, Jinhu,Chen, Pei,Chen, Kehao,Zhu, Jin
supporting information, p. 14508 - 14512 (2016/10/03)
A previously elusive RuII-catalyzed N?N ...
TRICYCLIC INDOLE MCL-1 INHIBITORS AND USES THEREOF
-
Paragraph 0429; 0443, (2016/05/19)
The present invention provides for compo...
104255-56-3 Process route
-
-
63169-10-8
4-nitroso-3,4-dihydro-2H-benzo[b][1,4]oxazine
-
-
104255-56-3
3,4-Dihydro-2H-1,4-benzoxazin-4-amine
| Conditions | Yield |
|---|---|
|
With
lithium aluminium tetrahydride;
In
tetrahydrofuran;
at 0 ℃;
for 2h;
Inert atmosphere;
|
44.9%
|
|
With
lithium aluminium tetrahydride;
In
tetrahydrofuran;
for 1h;
Yield given;
Heating;
|
|
|
With
lithium aluminium tetrahydride;
In
tetrahydrofuran;
at 20 ℃;
for 1h;
Inert atmosphere;
Cooling with ice;
|
|
|
With
ammonium chloride; zinc;
for 4.5h;
|
-
-
5735-53-5
1,4-benzoxazine
-
-
104255-56-3
3,4-Dihydro-2H-1,4-benzoxazin-4-amine
| Conditions | Yield |
|---|---|
|
Multi-step reaction
with
2
steps
1: NaNO2
, aq. H2
SO4
/ CH2
Cl2
2: LiAlH4
/ tetrahydrofuran / 1 h / Heating
With
lithium aluminium tetrahydride; sulfuric acid; sodium nitrite;
In
tetrahydrofuran; dichloromethane;
|
|
|
Multi-step reaction
with
2
steps
1: acetic acid / water / 1.17 h / 0 - 10 °C
2: lithium aluminium tetrahydride / tetrahydrofuran / 1 h / 20 °C / Inert atmosphere; Cooling with ice
With
lithium aluminium tetrahydride; acetic acid;
In
tetrahydrofuran; water;
|
|
|
1,4-benzoxazine;
With
hydrogenchloride; sodium nitrite;
In
ethanol; water;
at 0 ℃;
for 0.25h;
Inert atmosphere;
With
sodium dithionite; sodium hydroxide;
In
ethanol; water;
at 0 - 90 ℃;
for 2h;
|
|
|
Multi-step reaction
with
2
steps
1: hydrogenchloride; sodium nitrite / water / 2 h / 0 °C / Inert atmosphere
2: lithium aluminium tetrahydride / tetrahydrofuran / 2 h / 0 °C / Inert atmosphere
With
hydrogenchloride; lithium aluminium tetrahydride; sodium nitrite;
In
tetrahydrofuran; water;
|
104255-56-3 Upstream products
-
63169-10-8
4-nitroso-3,4-dihydro-2H-benzo[b][1,4]oxazine
-
5735-53-5
1,4-benzoxazine
-
98491-38-4
3,4-dihydro-2H-benzo[b][1,4]oxazine hydrochloride
-
7169-34-8
3-oxo-2,3-dihydrobenzo[b]furan
104255-56-3 Downstream products
-
1576240-08-8
(6bS, 11aS)-4-(1,2,6b,7,8,10,11,11a-octahydro-9H-azepino[4,5-b][1,4]oxazino[2,3,4-hi]indol-9-yl)-1-(4-fluorophenyl)-1-butanone